Hypernatremia in critically ill patients with Covid-19

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021611

Enrollment

Registered

2020-05-12

Start date

2020-05-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E87 U07.1

Interventions

Group 1: patients with covid-19 treated on the icu. no new exams are being conducted. This study only looks retrospectively at the data collected while treating the patients. These include lab results

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: group 1: patients with positive PCR for SARS-CoV-19 and treatment on ICU, respiratory symptoms with acute onset; bilateral diffuse infiltrates in imaging; interstitial edema, not explained by cardiac causes; paO2/FiO2 < 300 mmHg group 2: patients with positive PCR for SARS-CoV-19 and treatment on general ward, no ventilation

Exclusion criteria

Exclusion criteria: group 1&2: PCR for SARS-Cov-2 repeatedly negative all groups: preexisting end stage renal failure with dialysis

Design outcomes

Primary

Measure	Time frame
absolute numbers and dynamic of sodium levels	—

Secondary

Measure	Time frame
classification of hypernatremia	—

Countries

Germany

Contacts

Public ContactMilena Zimmer

Ortenauklinikum, Betriebsstelle Lahr

milena.zimmer@ortenau-klinikum.de07821931113

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026